The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A retrospective observational study of rapid titration of venetoclax (VEN) in patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL).
 
Tijesuni Babalola
No Relationships to Disclose
 
Emily C. Ayers
No Relationships to Disclose
 
Michael G. Douvas
Research Funding - Pfizer (Inst)
 
Laahn Foster
No Relationships to Disclose
 
John Densmore
No Relationships to Disclose
 
Michael E. Williams
Consulting or Advisory Role - AstraZeneca; Beigene; Celgene; Janssen Oncology; Kite/Gilead; Zentalis
Research Funding - Janssen (Inst); Kymera (Inst); Loxo/Lilly (Inst); Pharmacyclics (Inst)
 
Craig Anthony Portell
Consulting or Advisory Role - Abbvie; Aptitude Health; AstraZeneca; BeiGene; Carden Jennings; Curio Science; Janssen; Merck; Targeted Oncology
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Kite, a Gilead company (Inst); Loxo/Lilly (Inst); Merck (Inst); Prelude Therapeutics (Inst); Seagen (Inst); TG Therapeutics (Inst); VelosBio (Inst); Xencor (Inst)